Enanta Pharmaceuticals Total Revenue

Enanta Pharmaceuticals (ENTA) currently reports a total revenue of $65M as of June 2026. That compares with $65M in the prior-year period — up 0.7% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Enanta Pharmaceuticals's total revenue history and peer comparisons.

Enanta Pharmaceuticals's total revenue increased from $65M to $65M — a 0.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enanta Pharmaceuticals's total revenue of $65M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Enanta Pharmaceuticals reported $65M in total revenue as of June 2026. That compares with $65M in the prior-year period — up 0.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $65M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Enanta Pharmaceuticals, and consider following ENTA for alerts when major investors trade the stock.